MedPath

The Small Change Study to investigate the acceptability and feasibility of a small change approach to prevent weight gai

Not Applicable
Completed
Conditions
Weight management
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN18309466
Lead Sponsor
oughborough University
Brief Summary

2023 Results article in https://doi.org/10.1007/s10865-023-00455-1 (added 07/11/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
122
Inclusion Criteria

1. Aged =18 years
2. Body mass index 20 - 30 kg/m²
3. Access to an internet connection
4. Owns a smartphone
5. Has a UK mobile telephone number
6. Can speak and understand English

Exclusion Criteria

1. Participating in another weight management trial or programme
2. Inability or unwillingness to provide online consent
3. Pregnant/a planned pregnancy in the next 6 months
4.Taking weight loss medications/other medication that impacts weight
5. Have a history of an eating disorder in the last 5 years/are currently experiencing an eating disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. The acceptability and feasibility of an intervention that uses a small change approach to decrease calorie intake and/or increase energy expenditure to prevent weight gain, assessed using online questionnaires at weeks 2, 4, 6, 8, 10 and 12:<br> 1.1. The acceptability of the small change intervention will be assessed using questions that will focus on assessing whether they adhered to the small change approach, whether participants liked using this approach and whether participants found it helpful to reduce their calorie intake behaviour. The questions will also assess whether the trial materials (educational video, text messages, small change diary and list of 20 suggested small dietary and physical activity changes) were helpful.<br> 1.2. The feasibility of the small change intervention will be assessed using the number of participants randomised per month and the retention rates at follow-ups<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath